ID

14365

Descripción

Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00490243

Link

https://clinicaltrials.gov/show/NCT00490243

Palabras clave

Versiones (1)
  1. 12/4/16 12/4/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

12 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Asthma NCT00490243

Inglés

Eligibility Asthma NCT00490243

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00490243
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female outpatients
Descripción

outpatients

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0029921
aged 6 to 18 with a clinical diagnosis of bronchial asthma with a duration of at least 6 months before the first visit and with current history of moderate persistent asthma
Descripción

age and asthma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0004096
UMLS CUI [3]
C1960047
sensitive to house dust mites as shown by positive skin-prick tests to dermatophagoides pteronyssinus or dermatophagoides farinae
Descripción

sensitive to house dust mites

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3539110
UMLS CUI [2]
C0430561
to become eligible for the active treatment period, patients and their parents were required to do reproducible spirometry, whole body plethysmography and interrupter technique.
Descripción

spirometry, whole body plethysmography and interrupter technique

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0037981
UMLS CUI [2]
C0032224
in order to be included in the study the patients had to have a resting fev1 of more or equal 70%.
Descripción

fev1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0748133
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
study exclusions included:
Descripción

exclusion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2828389
active upper respiratory tract infection within 3 weeks before the study and acute sinus disease requiring antibiotic treatment within 1 month before the study
Descripción

respiratory tract infection and acute sinus disease requiring antibiotic treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0035243
UMLS CUI [1,2]
C0040223
UMLS CUI [2]
C0037199
UMLS CUI [3]
C0003232
previous intubation
Descripción

intubation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021925
asthma hospitalisation during the 3 months before the first visit.
Descripción

asthma hospitalisation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0004096
additional criteria were other clinically significant pulmonary, hematologic, hepatic, gastrointestinal, renal, endocrine, neurologic, cardiovascular, and/or psychiatric diseases or malignancy that either put the patient at risk when participating in the study or could influence the results of the study or the patient's ability to participate in the study as judged by the investigator.
Descripción

comorbidity limiting study protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
excluded medications were β-blockers (eye drops included), astemizole within 3 months, or oral corticosteroids within 1 month before the first visit.
Descripción

beta-blockers, astamizole, oral corticosteroids

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0304516
UMLS CUI [2]
C0001617
patients who were receiving immunotherapy were also excluded.
Descripción

immunotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021083
Volver a la parte superior de la página

Similar models

Eligibility Asthma NCT00490243

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00490243
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
outpatients
Item
male and female outpatients
boolean
C0029921 (UMLS CUI [1])
age and asthma
Item
aged 6 to 18 with a clinical diagnosis of bronchial asthma with a duration of at least 6 months before the first visit and with current history of moderate persistent asthma
boolean
C0001779 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
C1960047 (UMLS CUI [3])
sensitive to house dust mites
Item
sensitive to house dust mites as shown by positive skin-prick tests to dermatophagoides pteronyssinus or dermatophagoides farinae
boolean
C0020517 (UMLS CUI [1,1])
C3539110 (UMLS CUI [1,2])
C0430561 (UMLS CUI [2])
spirometry, whole body plethysmography and interrupter technique
Item
to become eligible for the active treatment period, patients and their parents were required to do reproducible spirometry, whole body plethysmography and interrupter technique.
boolean
C0037981 (UMLS CUI [1])
C0032224 (UMLS CUI [2])
fev1
Item
in order to be included in the study the patients had to have a resting fev1 of more or equal 70%.
boolean
C0748133 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
exclusion
Item
study exclusions included:
boolean
C2828389 (UMLS CUI [1])
respiratory tract infection and acute sinus disease requiring antibiotic treatment
Item
active upper respiratory tract infection within 3 weeks before the study and acute sinus disease requiring antibiotic treatment within 1 month before the study
boolean
C0035243 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0037199 (UMLS CUI [2])
C0003232 (UMLS CUI [3])
intubation
Item
previous intubation
boolean
C0021925 (UMLS CUI [1])
asthma hospitalisation
Item
asthma hospitalisation during the 3 months before the first visit.
boolean
C0019993 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
comorbidity limiting study protocol
Item
additional criteria were other clinically significant pulmonary, hematologic, hepatic, gastrointestinal, renal, endocrine, neurologic, cardiovascular, and/or psychiatric diseases or malignancy that either put the patient at risk when participating in the study or could influence the results of the study or the patient's ability to participate in the study as judged by the investigator.
boolean
C2348563 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
beta-blockers, astamizole, oral corticosteroids
Item
excluded medications were β-blockers (eye drops included), astemizole within 3 months, or oral corticosteroids within 1 month before the first visit.
boolean
C0304516 (UMLS CUI [1])
C0001617 (UMLS CUI [2])
immunotherapy
Item
patients who were receiving immunotherapy were also excluded.
boolean
C0021083 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial